MedPath

Follow-up of a randomized, double-blind, controlled clinical study on reducing postoperative recurrence and metastasis of colorectal cancer with Quxie Capsule

Phase 4
Completed
Conditions
Colorectal cancer
Registration Number
ITMCTR2100004249
Lead Sponsor
Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Patients with colorectal cancer diagnosed by pathology or cytology after radical resection.
(2) The surgical stage is stage A, B or C.
(3) Aged 18-75 years.
(4) Be willing to agree to participate in this study and cooperate with the follow-up according to the requirements of this study.

Exclusion Criteria

(1) There are non-neoplastic serious diseases and dysfunction in major organs such as liver, kidney and heart.
(2) Active cerebrovascular disease.
(3) Uncontrolled infectious and metabolic diseases.
(4) Pregnant women and mental patients.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Factors influencing patient survival rate and disease recurrence and metastasis rate (combined disease, KPS score);Survival index, 5,10,15 year survival;
Secondary Outcome Measures
NameTimeMethod
Recurrence rate at 5,10,15 years;
© Copyright 2025. All Rights Reserved by MedPath